Viracta Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Viracta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Viracta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.25M, a 29.6% decline year-over-year.
  • Viracta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.25M, a 22.3% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.65M, a 43.5% decline from 2022.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 144% increase from 2021.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.54M, a 1493% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.25M $1.25M -$525K -29.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6.77M $1.38M -$601K -30.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.37M $1.84M -$275K -13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.65M $1.78M -$390K -17.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $8.04M $1.78M -$5.87M -76.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $13.9M $1.98M +$21K +1.07% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $13.9M $2.11M +$340K +19.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $13.5M $2.17M +$366K +20.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $13.2M $7.65M +$5.94M +349% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.24M $1.96M +$570K +41.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.67M $1.77M +$1.13M +175% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $5.54M $1.81M +$1.71M +1823% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.83M $1.7M +$1.6M +1604% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.22M $1.39M +$1.32M +1938% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $906K $644K +$558K +649% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $348K $94K +$742K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$394K $100K -$365K -78.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$29.4K $68K -$326K -82.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $297K $86K -$331K -79.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $628K -$648K -$1.1M -243% Oct 1, 2019 Dec 31, 2019 8-K/A 2021-03-23
Q3 2019 $1.73M $465K -$172K -27% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.9M $394K -$258K -39.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $2.16M $417K -$479K -53.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.64M $452K -$157K -25.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $2.79M $637K +$136K +27.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.66M $652K -$384K -37.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $3.04M $896K +$9K +1.02% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $3.03M $609K -$432K -41.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $3.47M $501K -$590K -54.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $4.06M $1.04M -$170K -14.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $4.23M $887K -$566K -39% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $4.79M $1.04M -$668K -39.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $5.46M $1.09M -$212K -16.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $5.67M $1.21M -$162K -11.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $5.83M $1.45M -$511K -26% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $6.34M $1.71M -$105K -5.79% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $6.45M $1.3M -$332K -20.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $6.78M $1.37M -$96K -6.56% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $6.88M $1.96M +$658K +50.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $6.22M $1.81M +$826K +83.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $5.39M $1.64M +$602K +58.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $4.79M $1.46M +$351K +31.5% Mar 31, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $4.44M $1.31M +$555K +73.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $3.89M $988K +$283K +40.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $3.6M $1.03M +$159K +18.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $3.44M $1.11M +$536K +92.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $2.91M $751K +$183K +32.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $2.72M $705K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $874K +$345K +65.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $577K +$442K +327% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $568K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $529K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $135K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.